p.Y317H is a new JAK2 gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with CALR mutation

• Laura Eder-Azanza,
• Cristina Hurtado,
• David Navarro-Herrera,
• Paula Aranaz,
• Francisco J. Novo,
• José L. Vizmanos

Affiliations

Laura Eder-Azanza

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona;Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

Cristina Hurtado

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona;Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

David Navarro-Herrera

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona

Paula Aranaz

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona

Francisco J. Novo

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona;Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

José L. Vizmanos

University of Navarra, School of Sciences. Department of Biochemistry & Genetics, Pamplona;Navarra Institute for Health Research (IdiSNA), Pamplona, Spain